FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    1 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Trazodone 150mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Trazodone 100mg capsules (Bristol Laboratories Ltd) 56 capsule 4 x 14 capsules Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Trazodone 100mg capsules (Bristol Laboratories Ltd) 56 capsule 4 x 14 capsules Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Rabeprazole 10mg gastro-resistant tablets (Bristol Laboratories Ltd) 28 tablet 4 x 7 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Rabeprazole 10mg gastro-resistant tablets (Bristol Laboratories Ltd) 28 tablet 4 x 7 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Rabeprazole 20mg gastro-resistant tablets (Bristol Laboratories Ltd) 28 tablet 4 x 7 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Rabeprazole 20mg gastro-resistant tablets (Bristol Laboratories Ltd) 28 tablet 4 x 7 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Montelukast 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Montelukast 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Montelukast 4mg chewable tablets sugar free (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Montelukast 4mg chewable tablets sugar free (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Montelukast 5mg chewable tablets sugar free (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Montelukast 5mg chewable tablets sugar free (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 10mg tablets (Bristol Laboratories Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 10mg tablets (Bristol Laboratories Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) 1 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) 1 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) 10 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) 10 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) 1 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) 1 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) 10 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) 10 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Anagrelide 500microgram capsules (Sandoz Ltd) 100 capsule Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Anagrelide 500microgram capsules (Sandoz Ltd) 100 capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Liqua-E 500mg/5ml oral suspension (TriOn Pharma Ltd) Has concentration strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Liqua-E 500mg/5ml oral suspension (TriOn Pharma Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Carbocisteine 375mg capsules (Glenmark Pharmaceuticals Europe Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Carbocisteine 375mg capsules (Glenmark Pharmaceuticals Europe Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Enalapril 10mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Enalapril 10mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Enalapril 20mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Enalapril 20mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Metoprolol 50mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Metoprolol 50mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Metoprolol 100mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Metoprolol 100mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftazidime 2g powder for solution for injection vials (Fresenius Kabi Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 2g powder for solution for injection vials (Fresenius Kabi Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Fresenius Kabi Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Fresenius Kabi Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Fresenius Kabi Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Fresenius Kabi Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Amitriptyline 10mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amitriptyline 10mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Amitriptyline 25mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amitriptyline 25mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Amitriptyline 50mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amitriptyline 50mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nortriptyline 10mg tablets (Ria Generics Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nortriptyline 10mg tablets (Ria Generics Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nortriptyline 25mg tablets (Ria Generics Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nortriptyline 25mg tablets (Ria Generics Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Sertraline 100mg tablets (Ria Generics Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Sertraline 100mg tablets (Ria Generics Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Sertraline 50mg tablets (Ria Generics Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Sertraline 50mg tablets (Ria Generics Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Colchicine 500microgram tablets (Ria Generics Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Colchicine 500microgram tablets (Ria Generics Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nefopam 30mg tablets (Ria Generics Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nefopam 30mg tablets (Ria Generics Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Amantadine 100mg capsules (Accord Healthcare Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amantadine 100mg capsules (Accord Healthcare Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Fenofibrate micronised 267mg capsules (Accord Healthcare Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Fenofibrate micronised 267mg capsules (Accord Healthcare Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Co-amoxiclav 500mg/100mg powder for solution for injection vials (Sandoz Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Co-amoxiclav 500mg/100mg powder for solution for injection vials (Sandoz Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Co-amoxiclav 1000mg/200mg powder for solution for injection vials (Sandoz Ltd) Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Co-amoxiclav 1000mg/200mg powder for solution for injection vials (Sandoz Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Co-amoxiclav 1000mg/200mg powder for solution for injection vials (Sandoz Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Anagrelide 500microgram capsules (AOP Orphan Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Anagrelide 500microgram capsules (AOP Orphan Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Colchicine 500microgram tablets 84 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Colchicine 500microgram tablets 84 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Colchicine 500microgram tablets 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Colchicine 500microgram tablets 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nortriptyline 25mg tablets 84 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nortriptyline 25mg tablets 84 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nortriptyline 25mg tablets 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nortriptyline 25mg tablets 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nortriptyline 10mg tablets 84 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nortriptyline 10mg tablets 84 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nortriptyline 10mg tablets 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nortriptyline 10mg tablets 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Fluoxetine 60mg capsules 60 capsule Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Fluoxetine 60mg capsules 60 capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Liqua-E 500mg/5ml oral suspension (TriOn Pharma Ltd) 100 ml Has concentration strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Liqua-E 500mg/5ml oral suspension (TriOn Pharma Ltd) 100 ml Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Carbocisteine 375mg capsules (Glenmark Pharmaceuticals Europe Ltd) 120 capsule 12 x 10 capsules Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Carbocisteine 375mg capsules (Glenmark Pharmaceuticals Europe Ltd) 120 capsule 12 x 10 capsules Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Enalapril 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Enalapril 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Enalapril 20mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Enalapril 20mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Metoprolol 50mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Metoprolol 50mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Metoprolol 50mg tablets (Bristol Laboratories Ltd) 56 tablet 4 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1

    Start Previous Page 326 of 342 Next End

    This concept is not in any reference sets

    Back to Start